文献速递冠心病心力衰竭与心肌病心律失常

肾脏与肝脏移植受者心脏疾病的风险与管理

Risk and management of cardiac disease in kidney and liver transplant recipients.
PubMed 文献 · Heart · 2025-12-24

本文综述了肾脏和肝脏移植受者心血管疾病(CVD)风险增高的病理生理机制,涉及冠心病、心力衰竭、心律失常、瓣膜病和肺动脉高压等多种表型,并强调移植后体重增加、免疫抑制治疗及新发危险因素(如血脂异常和糖尿病)的叠加作用,最后提出需多学科管理移植后CVD风险。

要点

  • 肾/肝移植受者CVD风险涵盖冠心病、心衰、心律失常、瓣膜病和肺动脉高压。
  • 移植后体重增加、免疫抑制治疗及新发血脂异常/糖尿病共同增加CVD总风险。
  • 需提高对长期CVD风险的认识并采用多学科方法管理器官特异性CVD风险。

核心结论

  • 肾脏和肝脏移植受者长期CVD发病和心血管死亡风险高,需多学科管理。

研究设计与样本

  • 综述,总结肾/肝移植后短期和长期CVD风险增高的病理生理考虑及不同CVD表型。

主要发现

  • 移植受者CVD风险涵盖冠心病、心力衰竭、心律失常、瓣膜病和肺动脉高压。
  • 移植后体重增加、免疫抑制治疗及新发血脂异常和糖尿病共同增加CVD总风险。

临床怎么用

  • 临床应提高对肾/肝移植受者长期CVD风险的认识,采用多学科方法管理器官特异性CVD风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Organ transplantation is the treatment of choice for individuals with kidney failure requiring kidney replacement therapy, as well as for those with end-stage liver disease. Despite the significant reduction in long-term morbidity and mortality with transplantation, kidney and liver allograft recipients remain at high risk for cardiovascular disease (CVD) and premature death from cardiovascular causes. This heightened risk is represented across all phenotypes of CVD, including coronary heart disease, heart failure, arrhythmias, valvulopathies and pulmonary hypertension. Pre-existing vascular risk factors for CVD, coupled with superimposed cardiovascular-kidney-metabolic derangements after transplantation, driven at least in part by post-transplant weight gain, immunosuppressive therapies and de novo risk factors such as dyslipidaemia and diabetes, coalesce to increase total CVD risk. In this review, we summarise pathophysiological considerations for both the short- and long-term increase in CVD risk following kidney/liver transplantation. We review the different phenotypes of CVD, with unique considerations for post-transplant care in this patient population. Finally, we highlight the need for awareness about long-term CVD risk and a multidisciplinary approach to managing organ-specific CVD risk in kidney and liver transplant patients.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Shroff GR, Benjamin MM, Rangaswami J, et al. Risk and management of cardiac disease in kidney and liver transplant recipients. Heart. 2025. PMID: 40306758. doi:10.1136/heartjnl-2024-324796

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。